Spatial Distribution of the EGF Receptor in Regulation of Breast Epithelial Cell Growth and Organization.

Abstract

The spatial distribution of the EGF receptor and ligands is necessary for normal organization and proliferation of human mammary epithelial cells. We found that these cells express high levels of EGF receptors. These receptors are rapidly internalized and recycled. Unlike transformed cells, internalization efficiency of normal HMEC is high. These cells also make high levels of EGF, TGF-alpha, HB-EGF and amphiregulin, although TGF-alpha and amphiregulin appear to be the predominant ligands. We transfected cells with a gene encoding an artificial ligand consisting of the mature sequences of EGF (sEGF). Cells expressing sEGF could not be inhibited by antagonistic anti-EGF-R antibodies, apparently because the sEGF was working through an intracrine mechanism. Importantly, cells expressing sEGF could not organize correctly. Also, the ability of HMEC to spread and migrate on the extracellular matrix was dependent of EGF-R occupancy. Our data suggests that the ability to HMEC to spatially sense their environment is dependent on the EGF-R system through an autocrine mechanism. Importantly, these data support our hypothesis that disruptions in the spatial aspects of EGF-R signaling could facilitate the development of breast cancer.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 1995
Accession Number
ADA306441

Entities

People

  • H. S. Wiley

Organizations

  • University of Utah

Tags

DTIC Thesaurus Topics

  • Antibodies
  • Breast Cancer
  • Cell Physiological Processes
  • Cells
  • Chemistry
  • Diseases And Disorders
  • Epithelial Cells
  • Growth Factors
  • Kidney Diseases
  • Mammary Glands
  • Materials
  • Molecules
  • Neoplasms
  • Peptide Growth Factors
  • Proteins
  • Regulations
  • Spatial Distribution

Fields of Study

  • Biology

Readers

  • Aerial Delivery - Logistics and Supply Chain Management.
  • Neural Network Machine Learning.
  • Oncology (Cancer Research).